We demonstrated that, in distinction to classical opioid receptors, ACKR3 doesn't cause classical G protein signaling and is not modulated through the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists for example naloxone. Rather, we set up that LIH383, an ACKR3-selective subnanomolar https://richardf173xnd8.popup-blog.com/profile